Omega Healthcare Investors, Inc.

Fundamentals6.0
Price Action6.0
News Sentiment6.0
AI Rating
6.0

Key Drivers

  • High EBITDA margin
  • Payout > FCF
  • Low cash/liquidity

AI
AI Summary

6.0

OHI has shifted from a passive, high‑yield triple‑net REIT into an operator‑aligned capital allocator (JV/RIDEA/OpCo deals), which can drive upside but makes returns far more dependent on deal execution, operator credit outcomes, and dilution. The most actionable red flag is the dividend >100% of FCF with low cash on hand—expect potential cuts or dilutive financings absent clear conversion of AFFO into sustainable distributable cash, so monitor payout ratio, equity/OP issuance cadence, and large-operator recovery milestones.

CapitalAllocation
DividendRisk
Execution‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

6.0

Key Financial Insights:

  • High EBITDA margin
  • Payout > FCF
  • Low cash/liquidity

OHI generates strong REIT cash flow and high margins but funds dividends beyond free cash flow amid sizable debt repayments and minimal cash, creating payout and liquidity pressure despite solid interest coverage.

DividendRisk
Stable

Price Behavior

6.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Below last-month SMA
  • At range low
  • Sharp one-day drop

OHI is in a short-term downtrend, trading at last month's low near $44.79 below the ~$47.46 last-month SMA after a sharp one-day drop from $46.81 to $44.79, with nearest resistance around $48.40 and support at $44.79 indicating a short-term oversold/range-bound setup.

breakdown
range
Support Level: $44.79
Resistance Level: $48.40

Sharp decline from $46.81 on 2026-03-19 to $44.79 on 2026-03-20 indicating bearish momentum

Sentiment & News

6.0

Key News Insights:

  • Moderate Buy consensus
  • Institutional selling
  • Valuation debate

Analysts rate OHI as a "Moderate Buy" amid institutional selling and mixed valuation views, with investors debating REITs' appeal as high-dividend, inflation-resilient assets versus potential overvaluation.

Income
REITs

The mix of analyst support and recent share sales suggests short-term volatility, but OHI remains a candidate for yield-focused portfolios if valuations stabilize